Preclinical Tests Show Acid-Sensitive Nanoparticles Treat Ovarian Cancers With Little Toxicity
Last year, members of the Alliance for Nanotechnology in Cancer based at Northeastern University and the Massachusetts Institute of Technology demonstrated that acid-sensitive polymer nanoparticles could boost the delivery of anticancer drugs into the acidic interior of tumors.